Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppressive Therapy in Duchenne Muscular Dystrophy
2005-000663-26Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Mar 2005
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cyclosporine and prednisone in Duchenne muscular dystrophy (DMD) (2 arms), sponsored by Universitätsklinikum Freiburg. Primary endpoint: Manual Muscle Testing Score. Started Mar 2005; status: completed.
02
Drugs
cyclosporineprednisone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2005-000663-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000663-26.